Gender data rules; PTO hearing on patent terms

AIDS task force

WASHINGTON - The FDA plans to amend its regulations governing INDs and NDAs to require additional gender analysis, FDA Commissioner David Kessler said last week at a meeting of the National Task Force on AIDS Drug Development (NTFADD)...